- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02372968
Use of Metabonomics and Body Imaging for Metabolic Health Assessment
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The study will be carried out at the metabolic unit of the Nestlé Research Center (Lausanne). A large cohort of subjects will be recruited among Nestlé employees. Body composition will be determined by iDXA (Dual-energy X-ray absorptiometry) and basal metabolism will be measured by metabonomic analysis of urine and plasma samples.
Individual food habits and physical activities will be assessed by questionnaires.
The clinical protocol plans also the measurement of energy expenditure (EE) by indirect calorimetry on a subset of twenty subjects. These EE data will be used to validate iDXA outcomes for resting energy expenditure.
The volunteers can participate a second time to this study in the case they would like to control the evolution of their body composition and metabolism after a period of dietary regime or physical training. In such a case, a minimum period of two months between the visits is required.
After two days of dietary restrictions, the volunteers will come in the morning at the metabolic unit at fasting state, for urine and blood sampling. The metabolism of some foods can bias the metabonomic analyses. Therefore, the consumption of alcoholic beverages, fish meals, liquorice, grapefruit, power drinks and bars, spices, mineral supplements, soft drinks, chocolate, coffee and tea limited to 2 cups per day, are not allowed during two days preceding the visit. In addition, the intake of pain-killers or antiinflammatory drugs is forbidden during the two days before the sampling of urine and blood because their metabolism alters the metabolic profiles of blood and urine.
Antibiotics alter gut microflora, for which the activity represents an important contributor to the urinary metabolic profile. In order to preserve gut microflora-related metabolic information, we recommend a minimum period of one month between the end of any antibiotic therapy and the visit at the metabolic unit.
On the visit day, subjects will come fasting at the metabolic unit, where they will have to:
- Answer some medical questions during an interview with the doctor in charge of the study
- Fill in two questionnaires on food habits and physical activities. A dietician of the CHUV will visit you at NRC to ask you for some questions relative to your food habits. This is to validate the new questionnaire you filled in
- Give a sample of urine
- Undergo iDXA scan (2 consecutive measures will be run at each of the two visits, in order to assess the intra-individual variability of the results) and measure of the state of hydration by bioimpedance The analysis of plasma samples is recommended to complete the metabonomic analysis. However, the blood sampling will be freely decided by each participant. The protocol plans also to perform measurements of resting energy expenditure by indirect calorimetry on a subset of twenty subjects.
Study Type
Enrollment (Actual)
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
All subjects must comply with all the following inclusion criteria:
- Having respected dietary restrictions 2 days before the visit
- Having obtained his/her or his/her legal representative's informed consent
Exclusion Criteria:
Subjects representing one or more of the following criteria are excluded from participation in the study:
- Pregnancy as per precaution principal to avoid risks linked to X-ray exposure
Any pathology (infectious or other) having required an antibiotic therapy within
1 month prior to the beginning of the study
- Any therapy (contraception apart) within the 2 days before the visit day
- Subject who cannot be expected to comply with measures
- Currently participating or having participated in another clinical trial during the last 3 months prior to the beginning of this study
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Lean, fat, and bone mass (Measure of full body composition in lean, fat, and bone mass)
Time Frame: change of body composition after a period of 2 months following baseline
|
Measure of full body composition in lean, fat, and bone mass
|
change of body composition after a period of 2 months following baseline
|
|
Screening of metabolites in plasma in fasting condition
Time Frame: Change of plasma metabolites after a period of 2 months post baseline
|
Measure of plasma metabolites by Nuclear Magnetic Resonance spectroscopy and Mass Spectrometry
|
Change of plasma metabolites after a period of 2 months post baseline
|
|
Screening of urine metabolites in fasting condition
Time Frame: Change of urine metabolites after a period of 2 months post baseline
|
Measure of urine metabolites by Nuclear Magnetic Resonance spectroscopy and Mass Spectrometry
|
Change of urine metabolites after a period of 2 months post baseline
|
|
Food habits (Measure of food habits based on Food Frequency Questionnaires)
Time Frame: Change of food habits after a period of 2 months post baseline
|
Measure of food habits based on Food Frequency Questionnaires
|
Change of food habits after a period of 2 months post baseline
|
Collaborators and Investigators
Investigators
- Study Director: Serge Rezzi, PhD, Nestlé Institute of Health Sciences
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 08.03.MET
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy
-
University of Vermont Medical CenterAvocado Nutrition CenterRecruitingHealthy | Healthy Volunteers | Healthy Subjects | Healthy Volunteer | Healthy Adult | Healthy Volunteers Only | Healthy Male and Female Subjects | Healthy Non-smokersUnited States
-
Dragonfly TherapeuticsRecruitingHealthy | Healthy Participants | Healthy Adult Females | Volunteer | Healthy Adult MaleAustralia
-
University of PalermoCompletedHealthy | Healthy Volunteers | Healthy Subjects | Healthy Participants | Static Stretching | Stretch | StretchingItaly
-
Prevent Age Resort "Pervaya Liniya"RecruitingHealthy Aging | Healthy Diet | Healthy LifestyleRussian Federation
-
Yale UniversityNot yet recruitingHealth-related Benefits of Introducing Table Olives Into the Diet of Young Adults: Olives For HealthHealthy Diet | Healthy Lifestyle | Healthy Nutrition | CholesterolUnited States
-
Umm Al-Qura UniversityActive, not recruitingHealthy | Healthy Participants | Healthy Adult | Healthy Women | Healthy Adult Females | Healthy Adult Participants | Healthy Young Adults | Healthy Adult Female Participants | Healthy Adult Male | Poor Sleep Quality | Healthy (Controls) | Poor Sleeping Quality | Healthy Adult Male Subjects | Health Adult SubjectsSaudi Arabia
-
Maastricht University Medical CenterCompletedHealthy Volunteers | Healthy Subjects | Healthy AdultsNetherlands
-
University of PalermoCompletedHealthy Participants | Healthy Adult Participants | Healthy Young AdultsItaly
-
PfizerNot yet recruitingHealthy | Healthy AdultsUnited States
-
RAGE BioRecruitingHealthy | Healthy SmokerAustralia
Clinical Trials on Full body composition and of plasma and urine metabolites
-
Ankara UniversityCompletedInflammatory Bowel DiseaseTurkey
-
Rambam Health Care CampusCompletedSmoking Cessation | Muscle Weakness | Body Composition, BeneficialIsrael
-
Changi General HospitalCompletedObstructive Sleep Apnea | Pheochromocytoma | Catecholamine; SecretionSingapore
-
Biruni UniversityNot yet recruiting
-
University of Kansas Medical CenterRecruitingResting Metabolic Rate | Post Operative Nutrition | Metabolism; Disorder, PostproceduralUnited States
-
The University of Texas Health Science Center,...Baylor College of MedicineCompleted
-
Universidad Complutense de MadridCompleted
-
Torben Brøchner PedersenCompleted
-
University of Sao Paulo General HospitalCompleted
-
meral güvenAtaturk UniversityCompletedHyperbilirubinemia, NeonatalTurkey